The Rimonci Global Vision Index is designed to track the stock performance of listed companies doing business in ophthalmology and optometry. As of 08/10/19, the composite index consists of 106 companies, from small-cap growth companies to big pharmaceutical companies. The index is cap-weighted, and the respective market capitalization is adjusted based on the ratio of revenue generated from ophthalmology/optometry business to the overall revenue.
Besides the Rimonci Global Vision Index, we also design indexes to track the subsection of these listed companies. These indexes are Rimonci Pharmaceutical index (66 companies), Rimonci Medical Device index (36 companies), Rimonci Medical Service index (4 companies), Rimonci Small Cap Index (76 companies), Rimonci Mid Cap Index (18 companies), and Rimonci Large Cap index (12 companies).